SCHEMBL3598307

SCHEMBL3598307

CC#COC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3691355 0.78
SCHEMBL9572355 0.75
SCHEMBL11831715 0.74
SCHEMBL1943420 0.73
SCHEMBL6847839 0.73
SCHEMBL14118196 0.73
SCHEMBL4189242 0.70
SCHEMBL27547774 0.70
SCHEMBL28144542 0.69
SCHEMBL577189 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118373774-A Preparation method of 2-propyne-1-yl-1H-imidazole-1-carboxylic acid ester 景德镇富祥生命科技有限公司 2024-07-23 CN claimed
CN-118373774-A Preparation method of 2-propyne-1-yl-1H-imidazole-1-carboxylic acid ester 景德镇富祥生命科技有限公司 2024-07-23 CN disclosed
CN-118373774-A Preparation method of 2-propyne-1-yl-1H-imidazole-1-carboxylic acid ester 景德镇富祥生命科技有限公司 2024-07-23 CN disclosed
CN-115052879-B Compounds consisting of C20 modified salinomycin derivatives, process for obtaining them, compositions comprising them, use of the compounds and process for obtaining intermediates 菲莱克洛有限责任公司 2024-05-10 CN disclosed
CN-117624018-A Parami Wei Naxian guanidine derivative and preparation method and application thereof 广州中医药大学(广州中医药研究院) 2024-03-01 CN disclosed
CN-115052879-A Compound consisting of C20 modified salinomycin derivatives, method for obtaining same, composition comprising same, use of said compound and method for obtaining intermediate product 菲莱克洛有限责任公司 2022-09-13 CN disclosed
CN-107106708-B MRI imaging of amyloid plaques using liposomes 德克萨斯州儿童医院 2021-06-18 CN disclosed
CN-105307685-B Pyrrolobenzodiazepines Zhuo and its conjugate 麦迪穆有限责任公司 2019-03-08 CN disclosed
CN-105307685-A Pyrrolobenzodiazepines and conjugates thereof SPIROGEN SARL 2016-02-03 CN disclosed
CN-101535237-B Pentafluorophenyloxy compound, nonaqueous electrolytic solution and lithium secondary battery using the same UBE INDUSTRIES 2013-04-24 CN disclosed
US-8071637-B2 Dithiolopyrrolones compounds and their therapeutic applications WELICHEM BIOTECH INC. (CA) 2011-12-06 US disclosed
US-7794876-B2 Pentafluorophenyloxy compound, and nonaqueous electrolyte solution and lithium secondary battery using same UBE INDUSTRIES, LTD. (JP) 2010-09-14 US disclosed
US-20100041729-A1 DITHIOLOPYRROLONES COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS CELESTIAL PHARMACEUTICALS (SHENZHEN) LTD. (CN) 2010-02-18 US disclosed
CN-101535237-A Pentafluorophenyloxy compound, nonaqueous electrolytic solution and lithium secondary battery using the same UBE INDUSTRIES 2009-09-16 CN disclosed
EP-2076519-A2 NOVEL DITHIOLOPYRROLONES AND THEIR THERAPEUTICAL APPLICATIONS Celestial Pharmaceuticals (Shenzhen) LTD. (CN) 2009-07-08 EP disclosed
US-20080107969-A1 Pentafluorophenyl Methyl Oxalate; good electrical, cycling and storage properties; reacting pentafluorophenol with ethyl chloroglyoxylate UBE INDUSTRIES, LTD. (JP) 2008-05-08 US disclosed
WO-2008038175-A2 DITHIOLOPYRROLONES COMPOUNDS AND THEIR THERAPEUTIC APPLICATIONS CELESTIAL PHARMACEUTICALS (SHENZHEN) LTD. (CN) 2008-04-03 WO disclosed
US-4472300-A ANTIMICROBIAL FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-09-18 US disclosed
US-4237305-A INTERMEDIATES FOR PREPARING NEW ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-12-02 US disclosed
US-4207234-A 4-Unsubstituted azetidinone derivatives and process for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-06-10 US disclosed